James Edgemond - Net Worth and Insider Trading
James Edgemond Net Worth
The estimated net worth of James Edgemond is at least $3 Million dollars as of 2024-12-28. James Edgemond is the CFO AND TREASURER of United Therapeutics Corp and owns about 8,068 shares of United Therapeutics Corp (UTHR) stock worth over $3 Million. Details can be seen in James Edgemond's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James Edgemond has not made any transactions after 2024-11-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James Edgemond
James Edgemond Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James Edgemond owns 1 companies in total, including United Therapeutics Corp (UTHR) .
Click here to see the complete history of James Edgemond’s form 4 insider trades.
Insider Ownership Summary of James Edgemond
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| UTHR | United Therapeutics Corp | 2024-11-04 | CFO and Treasurer |
James Edgemond Latest Holdings Summary
James Edgemond currently owns a total of 1 stock. James Edgemond owns 8,068 shares of United Therapeutics Corp (UTHR) as of November 4, 2024, with a value of $3 Million.
Latest Holdings of James Edgemond
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| UTHR | United Therapeutics Corp | 2024-11-04 | 8,068 | 359.96 | 2,904,157 |
Holding Weightings of James Edgemond
James Edgemond Form 4 Trading Tracker
According to the SEC Form 4 filings, James Edgemond has made a total of 13 transactions in United Therapeutics Corp (UTHR) over the past 5 years, including 0 buys and 13 sells. The most-recent trade in United Therapeutics Corp is the sale of 7,778 shares on November 4, 2024, which brought James Edgemond around $3 Million.
Insider Trading History of James Edgemond
- 1
James Edgemond Trading Performance
James Edgemond Ownership Network
James Edgemond Owned Company Details
What does United Therapeutics Corp do?
Who are the key executives at United Therapeutics Corp?
James Edgemond is the CFO and Treasurer of United Therapeutics Corp. Other key executives at United Therapeutics Corp include President and COO Michael Benkowitz , EVP & General Counsel Paul A Mahon , and director & Chief Executive Officer Martine A Rothblatt .
United Therapeutics Corp (UTHR) Insider Trades Summary
Over the past 18 months, James Edgemond made 13 insider transaction in United Therapeutics Corp (UTHR) with a net sale of 133,718. Other recent insider transactions involving United Therapeutics Corp (UTHR) include a net sale of 707,954 shares made by Martine A Rothblatt , a net sale of 125,900 shares made by Paul A Mahon , and a net sale of 139,700 shares made by Michael Benkowitz .
In summary, during the past 3 months, insiders sold 215,531 shares of United Therapeutics Corp (UTHR) in total and bought 0 shares, with a net sale of 215,531 shares. During the past 18 months, 1,205,744 shares of United Therapeutics Corp (UTHR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,205,744 shares.
United Therapeutics Corp (UTHR)'s detailed insider trading history can be found in Insider Trading Tracker table.
United Therapeutics Corp Insider Transactions
James Edgemond Mailing Address
Above is the net worth, insider trading, and ownership report for James Edgemond. You might contact James Edgemond via mailing address: 1040 Spring Street, Silver Spring Md 20910.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
